Comparative effect of Nerlynx & HER2+positive & negative breast cancer cell lines on the barrier function of human brain endothelial cells

被引：0
|
作者：
Martin, Tracey Amanda [1 ]
Meyers, Isaac [1 ]
Appadurai, Emily [1 ]
Jiang, Wen G. [1 ]
机构：
[1] Cardiff Univ, Bridgend, Wales
来源：
CANCER RESEARCH | 2020年 / 80卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS19-P2-20-06
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-20-06
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Anticancer effect of zanubrutinib in HER2-positive breast cancer cell lines
    Dostalova, Hana
    Jorda, Radek
    Reznickova, Eva
    Krystof, Vladimir
    INVESTIGATIONAL NEW DRUGS, 2023, 41 (02) : 210 - 219
  • [2] Anticancer effect of zanubrutinib in HER2-positive breast cancer cell lines
    Hana Dostálová
    Radek Jorda
    Eva Řezníčková
    Vladimír Kryštof
    Investigational New Drugs, 2023, 41 : 210 - 219
  • [3] Radiosensitization of HER2-positive breast cancer cell lines with trastuzumab
    Alanyali, Senem Demirci
    Bozkurt, Emir
    Alanyali, Hilmi
    Karaca, Burcak
    Uslu, Ruchan
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [4] Effect of afatinib alone and in combination with trastuzumab in HER2-positive breast cancer cell lines
    Canonici, Alexandra
    Pedersen, Kasper
    Browne, Brigid
    McDermott, Martina
    Walsh, Naoml
    Crown, John
    O'Donovan, Norma
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [5] Classification of HER2-positive breast cancer cell lines based on proliferative activity in brain tissue
    Kuroiwa, Yuka
    Nakayama, Jun
    Yamamoto, Yusuke
    Watanabe, Shinya
    Semba, Kentaro
    CANCER SCIENCE, 2021, 112 : 361 - 361
  • [6] Drug Resistance in HER2-Positive Breast Cancer Brain Metastases: Blame the Barrier or the Brain?
    Kabraji, Sheheryar
    Ni, Jing
    Lin, Nancy U.
    Xie, Shaozhen
    Winer, Eric P.
    Zhao, Jean J.
    CLINICAL CANCER RESEARCH, 2018, 24 (08) : 1795 - 1804
  • [7] Disruption of the Blood Brain Barrier by Brain Metastases of Triple-Negative and Basal-Type Breast Cancer But Not HER2/neu-Positive Breast Cancer
    Yonemori, Kan
    Tsuta, Koji
    Ono, Makiko
    Shimizu, Chikako
    Hirakawa, Akihiro
    Hasegawa, Tadashi
    Hatanaka, Yutaka
    Narita, Yoshitaka
    Shibui, Soichiro
    Fujiwara, Yasuhiro
    CANCER, 2010, 116 (02) : 302 - 308
  • [8] Temsirolimus enhances the growth inhibitory effect of trastuzumab in HER2-positive breast cancer cell lines
    Kim, Elizabeth M. H.
    VanDusen, Hillary
    Lobocki, Catherine
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2010, 211 (03) : S121 - S121
  • [9] Establishment and characterization of novel highly aggressive HER2-positive and triple-negative breast cancer cell lines
    Thongchot, Suyanee
    Jamjuntra, Pranisa
    Prasopsiri, Jaturawitt
    Thuwajit, Peti
    Sawasdee, Nunghathai
    Poungvarin, Naravat
    Warnnissorn, Malee
    Sa-Nguanraksa, Doonyapat
    O-Charoenrat, Pornchai
    Yenchitsomanus, Pa-Thai
    Thuwajit, Chanitra
    ONCOLOGY REPORTS, 2021, 46 (06)
  • [10] Differential gene expression patterns in HER2/neu-positive and -negative breast cancer cell lines and tissues
    Wilson, KS
    Roberts, H
    Leek, R
    Harris, AL
    Geradts, J
    AMERICAN JOURNAL OF PATHOLOGY, 2002, 161 (04): : 1171 - 1185
12345